
ACA is a small organization with a big impact. The financial support of individuals like you is key to sustaining its vital work.
"Today, we both need to work to prevent the breakdown moment when guardrails against nuclear catastrophe evaporate, and be prepared to seize the breakthrough moment, when we can advance again in the direction of the security of a world free of nuclear weapons."
—ACA Board Chair, Tom Countryman, June 2024
U.S. President Donald Trump continues to allege, without evidence, that Iran’s nuclear program posed an imminent threat to the United States. The following are answers to frequently asked questions about Iran’s proliferation risk and nuclear security issues.
U.S. President Donald Trump and senior administration officials have offered conflicting justifications for the renewed U.S. strikes on Iran, including the claim that Iran’s nuclear and missile programs posed an imminent threat to the United States. There is no evidence, however, to support those claims. Read this issue brief for answers to FAQs on these claims.
When the Trump administration announced a joint declaration on U.S. nuclear cooperation with Saudi Arabia in November 2025, the White House claimed the proposed deal would lead to a “decades-long multi-billion-dollar nuclear energy partnership” with benefits to American nuclear companies. But U.S. officials dodged key questions about the nonproliferation obligations Saudi Arabia—a country that has openly threatened to develop nuclear weapons if Iran does—will be subject to under the proposed agreement.
On May 6, Amb. Do Hung Viet, the President of the 11th NPT Review Conference, circulated a relatively concise 13-page "zero draft" of the final conference document and invited states parties to begin offering their feedback. The document was put forward for review just 10 days into the month-long meeting and it takes a focused approach to each of the several major elements of the treaty and the dozens of issues that were raised in general debate statements in the previous days.